Bauerlein Alison's most recent trade in Sight Sciences Inc was a trade of 24,184 Common Stock done at an average price of $5.4 . Disclosure was reported to the exchange on July 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sight Sciences Inc | Alison Bauerlein | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 5.36 per share. | 02 Jul 2026 | 24,184 | 664,709 | - | 5.4 | 129,626 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 18 May 2026 | 12,728 | 688,893 | - | 5.1 | 65,167 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 3.48 per share. | 02 Apr 2026 | 25,874 | 701,621 | - | 3.5 | 90,042 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2026 | 127,512 | 727,495 | - | 0 | Common Stock | |
| Sight Sciences Inc | Alison Bauerlein | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.82 per share. | 05 Jan 2026 | 10,896 | 609,630 | - | 7.8 | 85,207 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.48 per share. | 05 Jan 2026 | 9,647 | 599,983 | - | 7.5 | 72,160 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2025 | 23,006 | 620,526 | - | 0 | Common Stock | |
| Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.30 per share. | 02 Oct 2025 | 19,948 | 597,520 | - | 3.3 | 65,828 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.10 per share. | 02 Jul 2025 | 19,260 | 617,468 | - | 4.1 | 78,927 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.48 per share. | 19 May 2025 | 13,066 | 636,728 | - | 3.5 | 45,430 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 02 Apr 2025 | 19,397 | 649,794 | - | 2.3 | 44,788 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 286,738 | 669,191 | - | 0 | Common Stock | |
| Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.52 per share. | 03 Jan 2025 | 10,102 | 382,453 | - | 3.5 | 35,579 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.08 per share. | 01 Oct 2024 | 10,130 | 392,555 | - | 6.1 | 61,590 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.21 per share. | 02 Jul 2024 | 10,497 | 402,685 | - | 6.2 | 65,207 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.42 per share. | 17 May 2024 | 13,066 | 413,182 | - | 5.4 | 70,870 | Common Stock |
| Sight Sciences Inc | Alison Bauerlein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 03 Apr 2024 | 10,123 | 426,248 | - | 5.1 | 51,415 | Common Stock |
| Sight Sciences Inc | Bauerlein Alison | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 315,421 | 436,371 | - | 0 | Common Stock | |
| Sight Sciences Inc | Alison Bauerlein | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 103,000 | 0 | - | 0 | Common Stock | |
| Sight Sciences Inc | Alison Bauerlein | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 71,800 | 71,800 | - | - | Stock Option (Right to Buy) | |
| Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 546 | 4,915 | - | - | Restricted Stock Unit | |
| Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 546 | 34,392 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Alison Bauerlein | EVP, Finance, & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.66 per share. | 01 Dec 2021 | 490 | 33,902 (0%) | 0% | 29.7 | 14,533 | Common Stock |